ClinicalTrials.Veeva

Menu

Feasibility Study to Actively Disseminate the Latin America and the Caribbean Code Against Cancer in Primary Healthcare Centers (FLACC-Brazil)

H

Hospital Israelita Albert Einstein

Status

Not yet enrolling

Conditions

Latin America and the Caribbean Code Against Cancer (LAC Code)
Cancer

Treatments

Behavioral: Combined WhatsApp Messaging and Online Workshop
Behavioral: WhatsApp-Based Cancer Prevention Messaging
Behavioral: Online Cancer Prevention Workshop for Healthcare Professionals

Study type

Interventional

Funder types

Other

Identifiers

NCT06965608
LACCODE - FLACC-Brazil

Details and patient eligibility

About

Phase II non-randomized four-arm study (before/after pragmatic trial) that will test 2 different implementation strategies either combined or separately for the dissemination of the Latin America and the Caribbean Code Against Cancer within four different primary healthcare units in Aparecida de Goiânia.

Enrollment

1,200 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Adults (≥18 years old)
  • Registered at a participating primary healthcare center (UBS) in Aparecida de Goiânia
  • Healthcare professionals with at least three months of employment at a participating UBS
  • Ability to provide informed consent

Exclusion criteria

  • Prior diagnosis of any cancer or currently undergoing cancer treatment

Trial design

Primary purpose

Health Services Research

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

1,200 participants in 4 patient groups

Control Group
No Intervention group
Description:
Participants in this arm will receive no intervention during the study period. They will complete baseline and follow-up assessments to evaluate changes in cancer prevention literacy and health services-related outcomes over time, serving as a comparison for the intervention arms.
G1: WhatsApp Messaging Intervention - General Population
Experimental group
Description:
Participants in this arm will receive structured cancer prevention messages via WhatsApp over a four-week period. The messages will cover key recommendations from the Latin America and the Caribbean Code Against Cancer (LAC Code), focusing on actionable steps to reduce cancer risk. Healthcare professionals (HCPs) assigned to this group will not receive any training.
Treatment:
Behavioral: WhatsApp-Based Cancer Prevention Messaging
G2: Online Workshop for Healthcare Professionals (HCP)
Experimental group
Description:
Description: Healthcare professionals (HCPs) in this arm will participate in an online, self-paced workshop designed to enhance their knowledge and communication skills related to cancer prevention. The workshop will provide evidence-based training on discussing cancer risk factors and prevention strategies with patients, aligning with the LAC Code recommendations. General population participants assigned to this group will not receive WhatsApp messages.
Treatment:
Behavioral: Online Cancer Prevention Workshop for Healthcare Professionals
G3: Combined Intervention (WhatsApp + Workshop)
Experimental group
Description:
This arm will integrate both intervention strategies. General population participants will receive WhatsApp messages with cancer prevention recommendations, while healthcare professionals will complete the online workshop. This combined approach aims to assess whether reinforcing cancer prevention messages at both the community and healthcare provider levels leads to improved outcomes in cancer prevention literacy and health services utilization.
Treatment:
Behavioral: Combined WhatsApp Messaging and Online Workshop

Trial contacts and locations

1

Loading...

Central trial contact

Diogo G Bugano, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems